Fluicell AB (publ)
STO: FLUI.ST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Stockholm Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Carolina Trjulja
- Employees
- 10
- Headquarters
- Mölndal, Sweden
- IPO year
- 2018
- Market cap
- SEK 45.9M
- Website
- https://www.fluicell.com
Loading FLUI…
Loading profile data…Frequently asked questions about FLUI
What does Fluicell AB (publ) (FLUI.ST) do?
Fluicell AB (publ) provides single-cell discovery platforms for biomedicine, drug development, and bioprinting applications worldwide. The company offers BioPen PRIME and BioPen FLEX microfluidic systems for maintaining localized solution delivery in single-cell experiments, as well as enabling control of the chemical environment around single i...
Where does FLUI.ST trade?
Fluicell AB (publ) (FLUI.ST) trades on the Stockholm Stock Exchange.
What sector is FLUI.ST in?
Fluicell AB (publ) (FLUI.ST) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Fluicell AB (publ)?
Carolina Trjulja is the chief executive officer of Fluicell AB (publ) (FLUI.ST).
Where is Fluicell AB (publ) headquartered?
Fluicell AB (publ) is headquartered in Sweden.
Does FLUI.ST pay a dividend?
Fluicell AB (publ) (FLUI.ST) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did FLUI.ST go public?
Fluicell AB (publ) (FLUI.ST) completed its initial public offering in 2018.